Ligand validation:2A06

JZR: hexyl beta-D-glucopyranoside

JZR is a Ligand Of Interest in 2A06 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2A06_JZR_A_4004	74%	50%	0.133	0.964	1.36	0.58	4	-	1	0	100%	1
2A06_JZR_P_3011	1%	38%	0.403	0.563	1.84	0.7	5	-	0	0	100%	1
2A06_JZR_C_2011	1%	38%	0.475	0.601	1.84	0.7	5	-	0	0	100%	1
2A06_JZR_S_2012	0%	37%	0.454	0.375	1.88	0.7	6	-	6	0	100%	1
2A06_JZR_F_4003	0%	38%	0.66	0.385	1.85	0.67	5	-	1	0	100%	1
2A06_JZR_F_3012	0%	36%	0.719	0.169	1.89	0.73	5	-	3	0	100%	1
1PPJ_JZR_A_4004	72%	44%	0.133	0.957	1.58	0.62	3	-	0	0	100%	1
1PP9_JZR_P_3008	1%	38%	0.397	0.567	1.83	0.68	6	-	0	0	100%	1
1YQ3_JZR_C_142	66%	19%	0.129	0.936	2.16	1.5	6	4	1	0	100%	1
1YQ4_JZR_C_142	59%	29%	0.151	0.933	2	0.99	3	2	0	0	100%	1
3PEQ_JZR_B_478	49%	60%	0.143	0.888	0.33	1.16	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.